The SRT-Tag (SRTag) is a 10-amino acid epitope (TFIGAIATDT) derived from the crystalline surface layer protein of Rickettsia typhi. This sequence is specifically recognized by the mouse monoclonal antibody SRT10, which was originally developed against this bacterial protein. The tag can be genetically fused to proteins of interest, enabling their detection and purification using the SRT10 antibody .
The SRT-Tag system offers several advantages similar to other epitope tag systems. Like common epitope tags (FLAG, HA, Myc), it enables protein detection without requiring antibodies against the protein of interest itself. The SRT-Tag has been successfully used for various applications including immunoblotting, immunocytochemistry, and immunoprecipitation. Its relatively small size (10 amino acids) minimizes potential interference with protein function, structure, or localization .
The SRT10 monoclonal antibody has demonstrated effectiveness across multiple detection platforms. Research has confirmed its utility in:
Immunoblotting (Western blotting) for protein detection in cell lysates
Immunocytochemistry for visualizing protein localization in cells
Immunoprecipitation for isolating protein complexes
These methods have been validated with the SRT-Tag fused to various proteins including NCC27/CLIC1, MEF2D, and CD4 .
The SRT-Tag sequence can be incorporated into recombinant proteins through molecular cloning techniques. The oligonucleotide sequence encoding the SRTag epitope (TFIGAIATDT) is inserted into an expression vector containing multiple cloning sites. This allows the tag to be fused in-frame with the coding region of the gene of interest. For optimal implementation, researchers have successfully created mammalian expression vectors with the SRTag sequence, enabling the expression of fusion proteins with the tag positioned at either the N-terminus or C-terminus of the target protein .
When encountering inconsistent detection results with the SRT-Tag system, researchers should systematically evaluate several factors:
Epitope accessibility: The three-dimensional conformation of the fusion protein may obscure the SRTag epitope
Expression levels: Low expression of the tagged protein might result in signals below detection threshold
Antibody concentration optimization: Suboptimal primary or secondary antibody concentrations can affect signal-to-noise ratio
Detection system sensitivity: Different visualization methods (chemiluminescence, fluorescence) have varying sensitivity thresholds
Protein degradation: The tagged portion of the protein may be cleaved or degraded during sample processing
Fixation effects: For immunocytochemistry, different fixation methods may differentially preserve the epitope structure
Troubleshooting should proceed systematically through these potential variables to identify the limiting factor in the experimental system.
Optimization strategies for detecting SRT-tagged proteins in challenging cellular compartments (e.g., nucleus, mitochondria, membrane-bound organelles) include:
Permeabilization protocol modification: Enhanced permeabilization may be required for detecting proteins in membrane-bound organelles
Fixation method selection: Different fixation protocols (paraformaldehyde, methanol, acetone) may better preserve epitope accessibility in different cellular compartments
Signal amplification: Using signal enhancement systems for low-abundance proteins
Subcellular fractionation: Isolating specific cellular compartments prior to analysis
Counterstaining with organelle markers: Confirming proper subcellular localization with compartment-specific markers
The successful detection of SRT-tagged proteins in different cellular locations (as demonstrated with nuclear MEF2D and membrane-associated CD4) suggests broad applicability across cellular compartments .
For immunoprecipitation using the SRT10 antibody, researchers should consider:
Lysis buffer composition: Use buffers that preserve protein-protein interactions while effectively solubilizing the target protein
Antibody-to-bead coupling: Optimal coupling of SRT10 to protein A/G beads or other immunoprecipitation matrices
Binding conditions: Appropriate incubation time and temperature for maximizing antigen-antibody binding
Washing stringency: Balance between removing non-specific binding while preserving specific interactions
Elution methods: Consider both traditional elution under denaturing conditions and peptide-based elution using excess SRTag peptide for native protein recovery
The SRT10 antibody has been demonstrated to effectively immunoprecipitate SRT-tagged fusion proteins, confirming its utility in protein complex isolation .
The SRT-Tag system can be effectively implemented in protein purification strategies through several approaches:
Immunoaffinity chromatography: Immobilized SRT10 antibody columns can specifically capture SRT-tagged proteins
Peptide elution: Competitive elution using synthetic SRTag peptide allows gentle, non-denaturing recovery of purified proteins
Tandem purification: Combining SRT-Tag with other affinity tags (His, GST) for sequential purification steps to enhance purity
Scale considerations: The system has been applied to both analytical and preparative scale purifications
Studies have demonstrated successful immunoaffinity purification of SRT-tagged human creatine kinase using peptide elution methods, confirming the utility of this approach for protein purification .
Critical optimization parameters for immunocytochemistry using the SRT10 antibody include:
Fixation method: Different fixation protocols (paraformaldehyde, methanol, acetone) may affect epitope accessibility
Permeabilization conditions: Optimize detergent type and concentration for adequate antibody penetration while preserving cellular architecture
Blocking conditions: Determine optimal blocking reagents to minimize background signal
Antibody concentration: Titrate primary and secondary antibody concentrations for optimal signal-to-noise ratio
Incubation parameters: Optimize time, temperature, and buffer composition for antibody binding
Washing stringency: Balance between background reduction and signal preservation
Detection system selection: Choose appropriate visualization method (fluorescence, chromogenic) based on experimental requirements
Successful immunocytochemical detection of SRT-tagged proteins including NCC27/CLIC1, MEF2D, and CD4 demonstrates the versatility of this system across different protein types and cellular localizations .
The SRT-Tag system offers valuable approaches for protein-protein interaction studies:
Co-immunoprecipitation: Using SRT10 antibody to pull down SRT-tagged proteins along with their interaction partners
Proximity labeling: Combining SRT-Tag with enzyme-based proximity labeling techniques (BioID, APEX) to identify spatial protein relationships
Interaction domain mapping: Creating truncated SRT-tagged protein variants to map interaction domains
Competitive binding assays: Using excess SRTag peptide to disrupt/validate specific interactions
Interactome analysis: Coupling SRT-Tag immunoprecipitation with mass spectrometry for unbiased interaction partner identification
The system's demonstrated compatibility with immunoprecipitation protocols makes it well-suited for these applications .
When adapting the SRT-Tag system for live cell imaging, researchers should consider:
Antibody fragment engineering: Using Fab fragments or single-chain variable fragments (scFv) derived from SRT10 for improved cellular penetration
Membrane permeability: Developing cell-permeable antibody derivatives or using microinjection/electroporation for intracellular delivery
Fluorophore selection: Choosing appropriate fluorophores with minimal phototoxicity and photobleaching
Expression timing: Optimizing the timing between protein expression and imaging to maximize signal while minimizing perturbation
Alternative approaches: Considering recombinant expression of fluorescent protein-tagged anti-SRTag antibody fragments
While the current literature primarily describes fixed-cell applications, these considerations could guide adaptation for live cell imaging scenarios.
The SRT-Tag system can be integrated with various molecular biology techniques for advanced applications:
Multiplexed detection: Combining SRT-Tag with other epitope tags (FLAG, HA, Myc) for simultaneous detection of multiple proteins
CRISPR-Cas9 genome editing: Introducing the SRTag sequence into endogenous genes for tracking expression of native proteins
Inducible expression systems: Coupling SRT-tagged proteins with tetracycline or other inducible promoters for temporal control
Proteomics applications: Using SRT-Tag for affinity purification coupled with mass spectrometry (AP-MS)
Structural biology: Employing SRT-Tag for protein purification prior to structural characterization by X-ray crystallography or cryo-EM
The demonstrated versatility of the SRT-Tag in different experimental contexts suggests its potential compatibility with these advanced applications.
Researchers should consider several potential limitations when implementing the SRT-Tag system:
Cross-reactivity: Possible recognition of endogenous proteins containing sequences similar to SRTag
Expression system compatibility: Performance may vary across different expression systems (bacterial, yeast, insect, mammalian)
Structural impact: Potential effects on protein folding, function, or interactions depending on tag placement
Antibody production considerations: Dependency on continued availability of the SRT10 hybridoma or recombinant antibody production
Detection sensitivity threshold: Lower limits of detection compared to enzymatic or fluorescent protein tags
Understanding these potential limitations allows researchers to design appropriate controls and validation experiments when implementing the SRT-Tag system.